Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
VAALCO Energy, Inc. Spuds First Well in Phase Three Drilling Program Offshore Gabon
-
Sintana Energy Inc. Provides Rule 2.9 Announcement
-
Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+ in patients with first line advanced melanoma
-
The O2 and Music Venue Trust Forge Landmark Commitment to Fuel Future Talent
-
Equinor ASA: Share buy-back – fourth tranche for 2025
-
Infomaniak launches Euria, a free and sovereign AI that respects privacy and heats homes
-
OSB GROUP PLC - Transaction in Own Shares
-
NBPE Announces Transaction in Own Shares
-
Transaction in Own Shares
-
DÉKUPLE UNVEILS ITS AMBITION 2030 STRATEGIC PLAN AND OPENS A NEW CHAPTER OF PROFITABLE AND SUSTAINABLE GROWTH IN EUROPE
-
Progress on share buyback programme
-
OPINION OF THE SUPERVISORY BOARD OF AKTSIASELTS EKSPRESS GRUPP IN RESPECT OF TAKEOVER BID
-
Elis: Disclosure of trading in own shares occured from December 4 to December 5, 2025
-
Bathroom Remodeling Expert Mark McManus Shares Winterproof Home Design Advice in HelloNation
-
Screen Printing Expert Ian Browning of Tucson Offers Guidance on Ordering Custom Screen Printing in HelloNation
-
Master-Planned Communities Expert Tim Ryan Explores How Traditional Neighborhood Developments Build Strong Community Spaces in HelloNation
-
Chiropractic Expert Dr. Kevin D. Trembush of Morgantown Shares What to Expect During Your First Chiropractic Visit in HelloNation
-
OSE Immunotherapeutics Unveils 2026–2028 Strategic Plan With Four Opportunities for Value Creation
-
Sampo plc’s share buybacks 8 December 2025
-
Roche launches new PCR test to help improve diagnostic accuracy for women affected by vaginitis in countries following the CE Mark
-
RENOVOICE Launches AI Search Reputation Framework to Help Financial Brands
-
Start of Day Message
-
Renault Group and Ford form a strategic partnership for passenger and commercial vehicles, starting with two affordable electric cars in Europe
-
Ascom appoints David Hale as new CEO
-
European Commission approves Roche’s Gazyva/Gazyvaro for adults with active lupus nephritis
-
Net Asset Value of EfTEN Real Estate Fund AS as of 30 November 2025
-
Arcadis reports transactions under its current share buyback program
-
On The Go TV Launches Streaming Platform Amid Evolving Consumer Preferences
-
2025 Assessment Finds U.S. Cities Are Taking Action to Advance Health Policy; 11 Improve Overall Medal Status
-
Responding to Change through Reform Pursuing Development through Transformation, 2025 Imperial Springs Int'l Forum Concludes with In-Depth Discussions on Global Economic Trends
-
Nantong, Jiangsu: E-commerce Training Helps Enterprises Enhance Digital Marketing and Cross-border Operations
-
Daedalus Special Acquisition Corp. Announces the Upsized Pricing of $225 Million Initial Public Offering
-
The Collegiate Cricket League Announces The 2026 Collegiate Cup® Location at Broward County Cricket Stadium
-
2025 Greater Bay Area Science Forum Kicks Off in Guangzhou, Focusing on Industry-Research Synergy
-
Minim Martap Development Update
-
Latest Data of InnoCare’s Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)
-
Netcapital Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Cygnus Metals Limited: Issue of Performance Rights
-
EnWave to Report Fourth Quarter and Annual 2025 Financial Results on December 15, 2025 and Host Investor Conference Call
-
Monument Mining Announces Results of Annual General Meeting of Shareholders
-
ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
-
ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%
-
ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant
-
RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO
-
Star Group, L.P. Reports Fiscal 2025 Full Year and Fourth Quarter Results
-
UPDATE - Broadway Star Morgan Dudley Joins Stargaze as Creative Advisor
-
AI UltraProd Announces U.S. Market Entry with Strategic Focus on High-Growth ADU Sector
-
Imviva Biotech Presents Validating Data for CAR-T Cell Therapies CTD402 and CTA311 in Five Presentations at the 67th American Society of Hematology Annual Meeting
-
UPDATED: TDECU Adds Two New Members to Board of Directors
-
Transocean Ltd. Announces $130 Million Award for Ultra-Deepwater Drillship
